KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Current Leases (2019 - 2025)

GoodRx Holdings' Current Leases history spans 7 years, with the latest figure at $4.8 million for Q4 2025.

  • For Q4 2025, Current Leases fell 15.67% year-over-year to $4.8 million; the TTM value through Dec 2025 reached $4.8 million, down 15.67%, while the annual FY2025 figure was $4.8 million, 15.67% down from the prior year.
  • Current Leases for Q4 2025 was $4.8 million at GoodRx Holdings, roughly flat from $4.8 million in the prior quarter.
  • Across five years, Current Leases topped out at $6.3 million in Q2 2021 and bottomed at $1.8 million in Q1 2023.
  • The 5-year median for Current Leases is $5.6 million (2024), against an average of $5.1 million.
  • The largest annual shift saw Current Leases plummeted 67.86% in 2023 before it skyrocketed 179.92% in 2024.
  • A 5-year view of Current Leases shows it stood at $5.9 million in 2021, then tumbled by 30.47% to $4.1 million in 2022, then soared by 51.84% to $6.2 million in 2023, then fell by 8.76% to $5.6 million in 2024, then fell by 15.67% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Current Leases are $4.8 million (Q4 2025), $4.8 million (Q3 2025), and $4.8 million (Q2 2025).